Heron Price To Sales Ratio from 2010 to 2024

HRTX Stock  USD 2.80  0.21  8.11%   
Heron Therapeuti Price To Sales Ratio yearly trend continues to be fairly stable with very little volatility. Price To Sales Ratio will likely drop to 1.76 in 2024. Price To Sales Ratio is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
1.84841079
Current Value
1.76
Quarterly Volatility
181.18504257
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron main balance sheet or income statement drivers, such as Depreciation And Amortization of 3 M, Interest Expense of 4.1 M or Total Revenue of 133.4 M, as well as many exotic indicators such as Price To Sales Ratio of 1.76, Dividend Yield of 0.0 or Days Sales Outstanding of 111. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.
  
This module can also supplement Heron Therapeuti's financial leverage analysis and stock options assessment as well as various Heron Therapeuti Technical models . Check out the analysis of Heron Therapeuti Correlation against competitors.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Latest Heron Therapeuti's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Heron Therapeuti over the last few years. Price to Sales Ratio is figured by comparing Heron Therapeuti stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Heron Therapeuti sales, a figure that is much harder to manipulate than other Heron Therapeuti multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. Heron Therapeuti's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heron Therapeuti's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 3.44 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Heron Price To Sales Ratio Regression Statistics

Arithmetic Mean141.38
Geometric Mean35.79
Coefficient Of Variation128.15
Mean Deviation164.71
Median28.04
Standard Deviation181.19
Sample Variance32,828
Range387
R-Value(0.54)
Mean Square Error25,177
R-Squared0.29
Significance0.04
Slope(21.74)
Total Sum of Squares459,592

Heron Price To Sales Ratio History

2024 1.76
2023 1.85
2022 2.53
2021 10.41
2020 21.68
2019 13.17
2018 24.51

About Heron Therapeuti Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Heron Therapeuti income statement, its balance sheet, and the statement of cash flows. Heron Therapeuti investors use historical funamental indicators, such as Heron Therapeuti's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Heron Therapeuti investors may use each financial statement separately, they are all related. The changes in Heron Therapeuti's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Heron Therapeuti's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Heron Therapeuti Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Sales Ratio 1.85  1.76 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Heron Therapeuti offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Heron Therapeuti's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Heron Therapeuti Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Heron Therapeuti Stock:
Check out the analysis of Heron Therapeuti Correlation against competitors.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Heron Stock analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is Heron Therapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heron Therapeuti. If investors know Heron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heron Therapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.80)
Revenue Per Share
0.92
Quarterly Revenue Growth
0.14
Return On Assets
(0.25)
Return On Equity
(24.09)
The market value of Heron Therapeuti is measured differently than its book value, which is the value of Heron that is recorded on the company's balance sheet. Investors also form their own opinion of Heron Therapeuti's value that differs from its market value or its book value, called intrinsic value, which is Heron Therapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heron Therapeuti's market value can be influenced by many factors that don't directly affect Heron Therapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heron Therapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heron Therapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heron Therapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.